Document is current
Any future updates will be listed below
-
Authors
Lanman, Tyler A.
Gross, Hana
Faria, Caylin M.
Miller, Julie J.
Cahill, Daniel P.
Shih, Helen A.
Zarrella, Giuliana V.
Dietrich, Jorg
Parsons, Michael W. https://orcid.org/0000-0001-8619-9564
- License Information
-
More Information
Article History
Received: 12 June 2025
Accepted: 4 July 2025
First Online: 23 July 2025
Declarations
:
: T.A.L. has received research support from American Society of Clinical Oncology/Sontag Foundation and the American Brain Tumor Association. D.P.C. has received financial compensation from Boston Scientific (2025), Servier (2023), and Incephalo (2023) for advisory input. D.P.C. has also received financial compensation and travel reimbursement from the US NIH and DOD for clinical trial and grant review (2024). H.A.S. received financial compensation from Servier for advisory input. J.D. is a consultant for Ono Pharmaceuticals and Amgen. J.D. is on the scientific advisory board of Johnson & Johnson, Janssen and Novartis. J.D. has received research support (to the institution) from Ono Pharmaceuticals. J.D. has received royalties for publishing work with Wolters Kluwer. J.J.M has received consulting fees from Servier and grant support from Massachusetts General Hospital, America Cancer Society, NINDS, NCI, and American Brain Tumor Association. M.W.P. has served as a consultant to Servier, Inc. The remaining authors do not have competing interests to disclose.
